Cao, Zhaoliu
Wang, Lili
Ma, Rui
Hu, Yun
Bao, Baiyi
Liu, Xiaohua
Li, Mengyuan
Wang, Xiao
Liu, Pingyu
Li, Xin
Funding for this research was provided by:
Nanjing Pharmaceutical Association-Changzhou SiYao Pharm Hospital Pharmacy Research Fund (2021YX024)
the National Natural Science Foundation of China (72074123)
Jiangsu Provincial Department of Science and Technology (No.BR2020043)
Article History
Received: 18 October 2023
Accepted: 8 July 2024
First Online: 11 July 2024
Declarations
:
: This study was performed under the guidance of the ethical approval document (No.: 2020103) approved by the Ethics Committee of Nanjing Medical University. Considering the non-involvement of direct personal identifiable data from human participants or animals, and non-commercial application of the research data, patients’ informed consent can be waived after the Ethics Committee approval, which is also in accordance with the informed consent waiving policy mentioned by the Article 39 of the Regulation of Ethical Review of Human Biomedical Research, issued by the National Health and Family Planning Commission of the People’s Republic of China in 2016. All procedures strictly followed the guidelines of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.